On November 2, Huang Guo, director of the China Drug Administration, met with Heidi Silo, Acting Director of WHO's Regulatory and Pre-Certification Department, and Martin Taylor, the representative in China, and his entourage in Beijing. The two sides had in-depth discussions on cooperation matters such as evaluation of WHO listed institutions, capacity building for supervision, and personnel exchanges.

On November 2, Huang Guo, director of the China Drug Administration, met with Heidi Silo, Acting Director of WHO's Regulatory and Pre-Certification Department, and Martin Taylor, the representative in China, and his entourage in Beijing. The two sides had in-depth discussions on cooperation matters such as evaluation of WHO listed institutions, capacity building for supervision, and personnel exchanges.